BROOKFIELD REINSURANCE LTD (BNRE) Fundamental Analysis & Valuation

NYSE:BNRE • BMG162501057

Current stock price

47.12 USD
-0.38 (-0.8%)
Last:

This BNRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BNRE Profitability Analysis

1.1 Basic Checks

  • BNRE had positive earnings in the past year.
  • In the past year BNRE had a positive cash flow from operations.
  • BNRE had positive earnings in 4 of the past 5 years.
  • In the past 5 years BNRE always reported a positive cash flow from operatings.
BNRE Yearly Net Income VS EBIT VS OCF VS FCFBNRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

1.2 Ratios

  • BNRE's Return On Assets of 0.78% is on the low side compared to the rest of the industry. BNRE is outperformed by 62.14% of its industry peers.
  • With a Return On Equity value of 9.30%, BNRE perfoms like the industry average, outperforming 44.29% of the companies in the same industry.
  • BNRE's Return On Invested Capital of 0.81% is in line compared to the rest of the industry. BNRE outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA 0.78%
ROE 9.3%
ROIC 0.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNRE Yearly ROA, ROE, ROICBNRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 10 20 30

1.3 Margins

  • The Profit Margin of BNRE (11.15%) is better than 70.71% of its industry peers.
  • In the last couple of years the Profit Margin of BNRE has grown nicely.
  • BNRE has a better Operating Margin (14.67%) than 66.43% of its industry peers.
  • In the last couple of years the Operating Margin of BNRE has grown nicely.
Industry RankSector Rank
OM 14.67%
PM (TTM) 11.15%
GM N/A
OM growth 3Y266.13%
OM growth 5YN/A
PM growth 3Y218.67%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BNRE Yearly Profit, Operating, Gross MarginsBNRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BNRE Health Analysis

2.1 Basic Checks

  • BNRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BNRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BNRE Yearly Shares OutstandingBNRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M 50M
BNRE Yearly Total Debt VS Total AssetsBNRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10B 20B 30B 40B

2.2 Solvency

  • The Debt to FCF ratio of BNRE is 2.54, which is a good value as it means it would take BNRE, 2.54 years of fcf income to pay off all of its debts.
  • BNRE has a Debt to FCF ratio (2.54) which is in line with its industry peers.
  • BNRE has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • BNRE has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: BNRE underperforms 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.54
Altman-Z N/A
ROIC/WACC0.12
WACC6.8%
BNRE Yearly LT Debt VS Equity VS FCFBNRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BNRE Yearly Current Assets VS Current LiabilitesBNRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BNRE Growth Analysis

3.1 Past

  • BNRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.20%.
  • BNRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 313.29% yearly.
  • BNRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.09%.
  • Measured over the past years, BNRE shows a very strong growth in Revenue. The Revenue has been growing by 111.15% on average per year.
EPS 1Y (TTM)-20.2%
EPS 3Y313.29%
EPS 5YN/A
EPS Q2Q%-75.61%
Revenue 1Y (TTM)49.09%
Revenue growth 3Y135.93%
Revenue growth 5Y111.15%
Sales Q2Q%48.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNRE Yearly Revenue VS EstimatesBNRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

Find the best growth stocksShow best growing peers

2

4. BNRE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 157.07, BNRE can be considered very expensive at the moment.
  • 84.29% of the companies in the same industry are cheaper than BNRE, based on the Price/Earnings ratio.
  • BNRE is valuated expensively when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 157.07
Fwd PE N/A
BNRE Price Earnings VS Forward Price EarningsBNRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, BNRE is valued cheaply inside the industry as 98.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.39
EV/EBITDA -5.76
BNRE Per share dataBNRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. BNRE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.66%, BNRE is not a good candidate for dividend investing.
  • BNRE's Dividend Yield is slightly below the industry average, which is at 2.37.
  • With a Dividend Yield of 0.66, BNRE pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

  • BNRE has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BNRE Yearly Dividends per shareBNRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BNRE Yearly Income VS Free CF VS DividendBNRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

BNRE Fundamentals: All Metrics, Ratios and Statistics

BROOKFIELD REINSURANCE LTD

NYSE:BNRE (9/5/2024, 8:12:56 PM)

47.12

-0.38 (-0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-08
Earnings (Next)N/A
Inst Owners1.48%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap795.38M
Revenue(TTM)9.11B
Net Income(TTM)1.01B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend0.76
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 157.07
Fwd PE N/A
P/S 0.09
P/FCF 0.39
P/OCF 0.36
P/B 0.07
P/tB 0.09
EV/EBITDA -5.76
EPS(TTM)0.3
EY0.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)119.55
FCFY253.72%
OCF(TTM)129.39
OCFY274.59%
SpS539.4
BVpS646.81
TBVpS497.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 9.3%
ROCE 1.03%
ROIC 0.81%
ROICexc 0.91%
ROICexgc 1.09%
OM 14.67%
PM (TTM) 11.15%
GM N/A
FCFM 22.16%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y266.13%
OM growth 5YN/A
PM growth 3Y218.67%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.54
Debt/EBITDA 3.5
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.61
Cash Conversion 149.38%
Profit Quality 198.82%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.8%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.2%
EPS 3Y313.29%
EPS 5YN/A
EPS Q2Q%-75.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.09%
Revenue growth 3Y135.93%
Revenue growth 5Y111.15%
Sales Q2Q%48.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.76%
EBIT growth 3Y763.81%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.58%
FCF growth 3Y47.68%
FCF growth 5Y55.77%
OCF growth 1Y19.21%
OCF growth 3Y52.3%
OCF growth 5Y58.72%

BROOKFIELD REINSURANCE LTD / BNRE Fundamental Analysis FAQ

What is the fundamental rating for BNRE stock?

ChartMill assigns a fundamental rating of 3 / 10 to BNRE.


What is the valuation status of BROOKFIELD REINSURANCE LTD (BNRE) stock?

ChartMill assigns a valuation rating of 2 / 10 to BROOKFIELD REINSURANCE LTD (BNRE). This can be considered as Overvalued.


What is the profitability of BNRE stock?

BROOKFIELD REINSURANCE LTD (BNRE) has a profitability rating of 4 / 10.


What is the valuation of BROOKFIELD REINSURANCE LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BROOKFIELD REINSURANCE LTD (BNRE) is 157.07 and the Price/Book (PB) ratio is 0.07.


What is the financial health of BROOKFIELD REINSURANCE LTD (BNRE) stock?

The financial health rating of BROOKFIELD REINSURANCE LTD (BNRE) is 2 / 10.